| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Common Stock | 7.69M | $146M | $19.00 | Jun 28, 2021 | Indirect |
| Trevi Therapeutics, Inc. | 10%+ Owner | Common Stock | 949K | $1.92M | $2.02 | Apr 11, 2022 | Indirect |
| Metacrine, Inc. | 10%+ Owner | Common Stock | 2.56M | $1.2M | $0.47 | Dec 22, 2021 | Indirect |
| Robinhood Markets, Inc. | Director | Class A Common Stock | 270 | $3.32K | $12.28 | May 2, 2022 | Indirect |
| Eargo, Inc. | 10%+ Owner | Common Stock | 821 | $2.13K | $2.59 | May 24, 2021 | Indirect |
| IonQ, Inc. | 10%+ Owner | Common Stock | 70 | $925 | $13.21 | Nov 16, 2022 | Indirect |
| Arcellx, Inc. | 10%+ Owner | Common Stock | 12 | $663 | $55.27 | Dec 20, 2022 | Indirect |
| AVEO PHARMACEUTICALS, INC. | 10%+ Owner | Common Stock | 24 | $360 | $15.00 | Oct 19, 2022 | Indirect |
| Desktop Metal, Inc. | 10%+ Owner | Class A Common Stock | 54 | $39.60 | $0.73 | Jun 8, 2021 | Indirect |
| Trevi Therapeutics, Inc. | 10%+ Owner | Pre-Funded Warrants | 3M | Apr 11, 2022 | Indirect | ||
| Bright Health Group Inc. | 10%+ Owner | Series B Convertible Perpetual Preferred Stock | 100K | Oct 17, 2022 | Indirect | ||
| Akouos, Inc. | 10%+ Owner | Common Stock | 0 | $12.50 | Nov 30, 2022 | Indirect | |
| GENOCEA BIOSCIENCES, INC. | 10%+ Owner | Common Stock | 0 | $1.25 | May 25, 2022 | Indirect | |
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series A-2 convertible preferred stock | 0 | Jun 28, 2021 | Indirect | ||
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series B convertible preferred stock | 0 | $2.00 | Jun 28, 2021 | Indirect | |
| Monte Rosa Therapeutics, Inc. | 10%+ Owner | Series C convertible preferred Stock | 0 | Jun 28, 2021 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACLX | Arcellx, Inc. | Dec 20, 2022 | 7 | $0 | 4 | Dec 22, 2022 | 10%+ Owner |
| AKUS | Akouos, Inc. | Nov 30, 2022 | 1 | $0 | 4 | Dec 2, 2022 | 10%+ Owner |
| IONQ | IonQ, Inc. | Nov 16, 2022 | 7 | $0 | 4 | Nov 18, 2022 | 10%+ Owner |
| AVEO | AVEO PHARMACEUTICALS, INC. | Oct 19, 2022 | 9 | $0 | 4 | Oct 21, 2022 | 10%+ Owner |
| BHG | Bright Health Group Inc. | Oct 17, 2022 | 2 | $138M | 4 | Oct 19, 2022 | 10%+ Owner |
| GNCA | GENOCEA BIOSCIENCES, INC. | May 24, 2022 | 2 | -$751K | 4 | May 26, 2022 | 10%+ Owner |
| HOOD | Robinhood Markets, Inc. | May 2, 2022 | 10 | $0 | 4 | May 4, 2022 | Director |
| TRVI | Trevi Therapeutics, Inc. | Apr 11, 2022 | 3 | $12.5M | 4 | Apr 13, 2022 | 10%+ Owner |
| HOOD | Robinhood Markets, Inc. | Jan 28, 2022 | 10 | $0 | 4 | Feb 1, 2022 | Director |
| BHG | Bright Health Group Inc. | Jan 3, 2022 | 2 | $200M | 4 | Jan 5, 2022 | 10%+ Owner |
| MTCR | Metacrine, Inc. | Dec 10, 2021 | 3 | -$494K | 4 | Dec 27, 2021 | 10%+ Owner |
| HOOD | Robinhood Markets, Inc. | Nov 10, 2021 | 4 | $0 | 4 | Nov 12, 2021 | Director |
| HOOD | Robinhood Markets, Inc. | Oct 27, 2021 | 4 | $0 | 4 | Oct 29, 2021 | Director, 10%+ Owner |
| TRVI | Trevi Therapeutics, Inc. | Oct 18, 2021 | 3 | $0 | 4 | Oct 19, 2021 | 10%+ Owner |
| HOOD | Robinhood Markets, Inc. | Aug 2, 2021 | 20 | $77.1M | 4 | Aug 3, 2021 | Director, 10%+ Owner |
| HOOD | Robinhood Markets, Inc. | Jul 29, 2021 | 0 | $0 | 3 | Jul 29, 2021 | Director, 10%+ Owner |
| BHG | Bright Health Group Inc. | Jun 28, 2021 | 22 | $35M | 4 | Jun 30, 2021 | 10%+ Owner |
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 28, 2021 | 7 | $20M | 4 | Jun 30, 2021 | 10%+ Owner |
| BHG | Bright Health Group Inc. | Jun 24, 2021 | 0 | $0 | 3 | Jun 24, 2021 | 10%+ Owner |
| GLUE | Monte Rosa Therapeutics, Inc. | Jun 23, 2021 | 0 | $0 | 3 | Jun 23, 2021 | 10%+ Owner |
| DM | Desktop Metal, Inc. | Jun 8, 2021 | 7 | $0 | 4 | Jun 10, 2021 | 10%+ Owner |
| EAR | Eargo, Inc. | May 24, 2021 | 4 | $0 | 4 | May 26, 2021 | 10%+ Owner |